INFLUENCE OF AGE AND TIME OF ADMINISTRATION OF DITHIOCARBAMATE ANALOGS ON CADMIUM RETENTION IN RATS

被引:8
作者
KARGACIN, B
KOSTIAL, K
AREZINA, R
SINGH, PK
JONES, MM
CIKRT, M
机构
[1] UNIV ZAGREB, INST MED RES & OCCUPAT HLTH, DEPT MINERAL METAB, M PIJADE 158, YU-41000 ZAGREB, CROATIA
[2] VANDERBILT UNIV, DEPT CHEM, NASHVILLE, TN 37235 USA
[3] VANDERBILT UNIV, CTR MOLEC TOXICOL, NASHVILLE, TN 37235 USA
[4] INST HYG & EPIDEMIOL, CS-10042 PRAGUE 10, CZECHOSLOVAKIA
关键词
CADMIUM; DITHIOCARBAMATE ANALOGS; AGE; RATS;
D O I
10.1002/jat.2550110408
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
In the present study the influence of age and time of chelation therapy on cadmium retention in 6-, 11-and 14-day-old rats and in 6-week-old rats has been investigated. Chelating agents N-benzyl-dithiocarboxy-D-glucamine (BDCG), sodium N-(metho-xybenzyl)-D-glucamine dithiocarbamate monohydrate (MeOBDCG) and N-methyl-N-dithiocarboxy-D-glucamine (MDCG) were administered intraperitoneally to three different groups at a dose of 1 mmol kg-1 body weight on two occasions following Cd-115m intraperitoneal administration; immediately and after 24 h; after 24 h and 48 h; or after 48 h and 72 h. The Cd-115m retention in the whole body and organs was determined 6 days after cadmium administration. Chelation therapy very effectively reduced cadmium retention in the whole body and organs, MeOBDCG being the most effective. The effects of chelating agents were significantly more pronounced in older than younger animals and in the case of early rather than late administration. The highest fraction of cadmium administered was retained in the liver, where also the strongest effect of chelation therapy was observed. Mobilized cadmium was excreted almost exlusively by the faecal route.
引用
收藏
页码:273 / 277
页数:5
相关论文
共 32 条
[1]  
BARTON JC, 1987, AGE RELATED FACTORS, P1
[2]   DECREASED EFFECTIVENESS OF CHELATION-THERAPY WITH TIME AFTER ACUTE CADMIUM POISONING [J].
CANTILENA, LR ;
KLAASSEN, CD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1982, 63 (02) :173-180
[3]  
CHERIAN MG, 1982, J PHARMACOL EXP THER, V222, P699
[4]  
EYBL IV, 1965, N-S ARCH PHARMACOL, V252, P85
[5]  
FRIBERG L, 1956, AMA Arch Ind Health, V13, P18
[6]   EFFECTS OF SODIUM N-METHYL-N-DITHIOCARBOXYGLUCAMINE ON CADMIUM DISTRIBUTION AND EXCRETION [J].
GALE, GR ;
SHINOBU, LA ;
JONES, MM ;
ATKINS, LM ;
SMITH, AB .
LIFE SCIENCES, 1984, 35 (25) :2571-2578
[7]  
GALE GR, 1981, ANN CLIN LAB SCI, V11, P476
[8]   N,N-DISUBSTITUTED DITHIOCARBAMATES AS CADMIUM ANTAGONISTS - N-(4-METHOXYBENZYL)-N-DITHIOCARBOXY-D-GLUCAMINE [J].
GALE, GR ;
ATKINS, LM ;
SMITH, AB ;
SINGH, PK ;
JONES, MM .
TOXICOLOGY LETTERS, 1989, 48 (01) :105-115
[9]  
JONES SG, 1983, RES COMMUN CHEM PATH, V40, P155
[10]   USE OF THE TOPLISS SCHEME FOR THE DESIGN OF MORE EFFECTIVE CHELATING-AGENTS FOR CADMIUM DECORPORATION [J].
JONES, SG ;
SINGH, PK ;
JONES, MM .
CHEMICAL RESEARCH IN TOXICOLOGY, 1988, 1 (04) :234-237